Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

9.90
Delayed Data
As of 4:00pm ET
 -0.35 / -3.41%
Today’s Change
2.65
Today|||52-Week Range
12.05
+224.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues2.8M8.9M3.4M8.3M
 
 
 
 
 
Depreciation And Amortization252.0K252.0K301.0K317.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses21.8M18.5M19.9M20.7M
 
 
 
 
 
Research And Development17.0M13.9M12.9M15.0M
 
 
 
 
 
Total Operating Expenses22.0M18.8M20.2M21.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.2M-9.8M-16.8M-12.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.0M-9.6M-16.6M-12.5M
 
 
 
 
 
Income Taxes-3.0K-13.0K0.000.00
 
 
 
Net Income-19.0M-9.6M-16.6M-12.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS70.6M70.7M71.0M72.5M
 
 
 
 
 
Shares To Calculate EPS Diluted70.6M70.7M71.0M72.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.14-$0.23-$0.17
 
 
 
 
 
EPS Diluted-$0.27-$0.14-$0.23-$0.17